Medicilon was named "2013 China's Top Ten Most Valuable CRO Enterprises”

In order to encourage the creativity of pharmaceutical industry enterprises, accelerate the transformation of high-tech achievements into productive pace, enhance the market competitiveness and promote innovation and development of China’s pharmaceutical industry, ”Medicine” Magazine and “Pharmsources.cn”launched a “2013 China’s Top 100 Pharmaceutical Industry Innovative Companies Award” in Beijing Exhibition on December 11-12.

After the selection by Chinese government, pharmaceutical experts, institutional researchers, pharmaceutical companies, pharmaceutical investors and some other pharmaceutical elites, Shanghai Medicine Inc. was named one of the “2013 China’s Top Ten Most Valuable CRO Enterprises.”